Neuralgia: clinical trials and information
Neuralgia clinical trials in Canada
| Phase | Provinces | ||||
|---|---|---|---|---|---|
| Intra-operative Lidocaine Infusion in Preventing CPSP Post VATs NCT02862769 | Unknown status | Phase 4 | Ontario | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2017-01-01 |
| Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain NCT03009500 | Completed | Phase 3 | Ontario | University Health Network, Toronto | 2017-01 |
Neuralgia clinical trials worldwide (outside Canada)
17 trials, 3 recruiting or not yet recruiting. Recruiting first.
About Neuralgia
What is Neuralgia?
Neuropathic pain is pain caused by damage to, or disease of, the nervous system. People describe it with words such as burning, shooting, stabbing or electric. It can follow conditions such as diabetes, shingles, nerve injury or chemotherapy.
How is Neuralgia usually assessed?
Clinicians usually assess neuropathic pain through a history and a neurological examination, sometimes with questionnaires designed to screen for nerve-related pain, and sometimes with nerve conduction studies or imaging.
What kinds of treatments are studied for Neuralgia?
Registered studies cover medicines, medical devices (such as nerve stimulators), procedures (such as nerve blocks or injections), physical and movement therapies, psychological approaches (such as cognitive behavioural therapy), education programs and digital tools. Being studied in a trial does not mean a treatment works or is approved. The interventions listed on this page come directly from the registry records.
How can I find Neuralgia clinical trials in Canada?
This page lists 2 registry records for this term with at least one site in Canada, recruiting studies first. Each trial page links to the official ClinicalTrials.gov record, which lists the study contacts. Recruiting status changes often, so check the registry, and talk to your doctor before joining a study.
Related conditions
Related interventions
Related US FDA drug labels
Labels whose indications text mentions this term. US labels, not Health Canada Product Monographs.
- Dehydrated Alcohol Injection
- FDA drug label 1d0a512a
- Dehydrated Alcohol Injection
- Dehydrated Alcohol Injection, USP
- Dehydrated Alcohol Injection, USP
- Dehydrated Alcohol Injection
- Dehydrated Alcohol Injection
- Dehydrated Alcohol Injection
- FDA drug label 5437ccae
- Dehydrated Alcohol Injection, USP
- FDA drug label 5a448eff
- Dehydrated Alcohol Injection
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status.